Lantern Pharma Inc.
$0.67
+0.00 (+0.24%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -60.9%
- 3 Months
- -77.3%
- YTD
- -77.9%
- 1 Year
- -84.9%
- 3 Year annualized
- -41.4%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 100.4%
- Largest decline max drawdown, since Oct 2021
- -93.9%
- Risk-adjusted return Sharpe ratio, 1-year
- -1.33
Own LTRN?
See how LTRN contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.